Medical Device Industry Regulatory and Quality Consultants
The consultants at Medical Devices and Pharma have decades of aggregated experience working with a variety of medical devices. That includes expert knowledge of regulations from the U.S. Food and Drug Administration (FDA), Health Canada (HC), the European Union (EU) and other global regulatory bodies.
We offer current information about new and novel medical devices, device safety alerts, industry news, and enforcement actions like FDA warning letters. Our regulatory specialists can expertly compile, prepare, and submit regulatory submissions for regulatory marketing authorization, like an FDA 510(k) premarket submission.
What is a medical device?
The definition of a medical device encompasses a wide range of complexity and purposes, from a walking cane to an artificial heart. It can be a physical apparatus or something like software or a chemical reagent.
Regardless of its form or composition, a product is defined as a medical device if it is used to diagnose a medical issue; alleviate, prevent or minimize the risk of a medical problem; or to provide medical treatment.
The differences between medical devices and pharmaceuticals.
Is your product a medical device?
Let us answer your questions about your medical device product, from device classification and requirements to establishment registration and device listings and requirements you need to follow in order to market the product in the U.S. Click here to contact us.
FDA definition of a medical device
An instrument, apparatus, implement, machine, contrivance, implant, in vitro reagent, or other similar or related article, including a component part or accessory which is:
- Recognized in the official National Formulary, or the United States Pharmacopoeia, or any supplement to them,
- Intended for use in the diagnosis of disease or other conditions, or in the cure, mitigation, treatment, or prevention of disease, in man or other animals, or
- Intended to affect the structure or any function of the body of man or other animals, and which does not achieve its primary intended purposes through chemical action within or on the body of man or other animals and
- Which does not achieve its primary intended purposes through chemical action within or on the body of man or other animals and which is not dependent upon being metabolized for the achievement of its primary intended purposes.
The term “device” does not include software functions excluded pursuant to section 520(o). Source: “Is the Product a Medical Device?“
Pre-amendment and post-amendment devices
Devices are also identified as pre-amendment or post-amendment based on when they received FDA market clearance. This makes a difference for how a manufacturer can put a device on the U.S. market.
Pre-amendment devices were on the market prior to the enactment of the Medical Device Amendments (MDA) of the Food, Drug and Cosmetic Act on May 28, 1976. They do not require a premarket approval (PMA) or premarket notification (510(k)) submission prior to market entry.
Post-amendment devices received marketing approval after the enactment of the MDA in 1976. Class III devices require the FDA approval of a PMA before the device can be sold on the market. Most class II and some class I devices require a 510(k) premarket notification submission to demonstrate that they are substantially equivalent to a medical device that is currently marketed in the U.S.
Medical Device Headlines
FDA-Approved Vivistim: A New Pathway in Stroke Recovery
Vivistim implantable vagus nerve stimulator. Source: Vivistim.com.FDA-Approved Vagus Nerve Stimulation Device Opens a New Pathway in Stroke Recovery A company behind one of the world’s most closely watched neurorehabilitation technologies is preparing for a major new...
FDA Warning Letter Cites Systemic Aseptic Manufacturing Failures
Medline Warning Letter Signals Systemic Quality Failures in Cardiovascular Device Manufacturing The FDA has issued a Warning Letter to Medline Industries (NAMIC Division) following a December 2025 inspection, identifying significant Quality System Regulation (QSR)...
April 2026 Update for FDA QMSR Inspection Results
April 2026 Update for FDA QMSR Inspection ResultsConfirming the Shift to System-Level, Risk-Based Inspection When FDA’s Quality Management System Regulation (QMSR) took effect on February 2, 2026, the regulatory framework became formally aligned with ISO 13485. What...
Merit Medical Dialysis Catheter Recall – Risk of Serious Injury
Merit Medical Removes 16F Dual-Valved Splittable Sheath Introducer Design Defect May Lead to Hemorrhage, Embolization, and Loss of Vascular Access The U.S. Food and Drug Administration (FDA) has identified a Class I recall involving Merit Medical’s 16F Dual-Valved...
Medline Recalls Angiographic RA Control Syringes
Angiographic Syringe Recall: Medline Removes RA Control Syringes Due to Risk of Disconnection and Air Embolism The U.S. Food and Drug Administration (FDA) has announced that Medline Industries has issued an Urgent Medical Device Recall involving certain Namic...
Class I Correction for Abiomed Impella Inaccurate Flow Readings
Abiomed Impella RP: FDA Class I Correction for Inaccurate Flow Readings Abiomed has issued an Urgent Medical Device Correction for its Impella RP with SmartAssist and Impella RP Flex with SmartAssist systems due to potential inaccuracies in displayed pump performance...
Class I Correction for Homecare Bed Fire and Entrapment Risks
Medline Homecare Beds: FDA Class I Correction for Fire and Entrapment Risks Medline Industries has issued a critical safety correction involving multiple models of homecare beds following reports of overheating components, electrical hazards, and patient entrapment...
When a Small Process Failure Becomes a Patient Safety Event
What the Erbe Cryoprobe Alert Teaches Us About Modern Device Quality The FDA’s recent Early Alert regarding flexible cryoprobes manufactured by Erbe USA is a textbook example of a fundamental truth in medical device quality. That small manufacturing deviations can...
FDA Flags High-Risk Issue with Erbe Flexible Cryoprobes
FDA Flags High-Risk Issue with Erbe Flexible Cryoprobes The FDA’s Center for Devices and Radiological Health (CDRH) has issued an Early Alert regarding a potentially high-risk issue involving certain flexible cryoprobes manufactured by Erbe USA. Issue Overview Erbe...
EPA Proposes Rollback of EtO Sterilization Emissions Limits
EPA Proposes Rollback of Ethylene Oxide Sterilization Emissions LimitsThe U.S. Environmental Protection Agency has proposed weakening restrictions on emissions of ethylene oxide (EtO) from commercial sterilization facilities that sterilize medical devices. EtO plays a...



